← Back to headlines
Mizuho Cuts Price Target for ADMA Biologics
Mizuho has lowered its price target for ADMA Biologics Inc. (ADMA) from $30 to $24. This adjustment reflects a revised outlook on the company's stock performance.
20 Apr, 00:12 — 20 Apr, 00:12
Sources
Showing 1 of 1 sources
